Hypercalcemia Causes and Treatment

Major Causes of Hypercalcemia

• Primary hyperparathyroidism is characterized by elevated or inappropriately normal parathyroid hormone (PTH) levels with hypercalcemia, according to the American College of Endocrinology 1
• Humoral hypercalcemia of malignancy is mediated by parathyroid hormone-related protein (PTHrP), often in squamous cell carcinomas and renal cell carcinoma, as noted by the National Comprehensive Cancer Network 1
• Granulomatous disorders, such as sarcoidosis, cause hypercalcemia due to increased 1,25-dihydroxyvitamin D production, as reported by the American Thoracic Society 1
• Vitamin D intoxication leads to hypercalcemia due to excessive supplementation or treatment, as warned by the Endocrine Society 2
• Williams syndrome is associated with idiopathic infantile hypercalcemia, according to the American Academy of Pediatrics 3

Clinical Presentation

• Moderate hypercalcemia presents with polyuria, polydipsia, nausea, vomiting, abdominal pain, and myalgia, as described by the American College of Physicians 1
• Severe hypercalcemia is associated with mental status changes, bradycardia, hypotension, dehydration, and acute renal failure, as reported by the Society of Critical Care Medicine 1
• In Williams syndrome, hypercalcemia may present with extreme irritability, vomiting, constipation, and muscle cramps in infants, as noted by the American Academy of Pediatrics 3

Diagnostic Approach

• Parathyroid hormone-related protein (PTHrP) is elevated in many cases of malignancy-associated hypercalcemia, as reported by the National Comprehensive Cancer Network 4
• Vitamin D metabolites, including 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels, should be measured to evaluate hypercalcemia, as recommended by the Endocrine Society 4, 1
• Renal function should be evaluated with serum creatinine and urinary calcium excretion, as suggested by the National Kidney Foundation 2
• Malignancy markers should be considered if PTH is suppressed, as recommended by the American Cancer Society 2

Treatment Approach

• Bisphosphonates are the first-line treatment for moderate to severe hypercalcemia, especially malignancy-associated, as recommended by the American Society of Clinical Oncology 1
• Glucocorticoids are effective for vitamin D-mediated hypercalcemia, such as in sarcoidosis, lymphomas, and vitamin D intoxication, as reported by the American College of Rheumatology 1
• Treatment of the underlying cancer is essential for malignancy-associated hypercalcemia, as emphasized by the National Comprehensive Cancer Network 2
• In patients with kidney disease, careful monitoring of renal function is necessary when using bisphosphonates, as warned by the National Kidney Foundation 2
• For Williams syndrome with hypercalcemia, a low-calcium diet and increased water intake under medical supervision are recommended, as suggested by the American Academy of Pediatrics 3
• Vitamin D supplements should be avoided in patients with hypercalcemia, as recommended by the Endocrine Society 4

Follow-up and Monitoring

• Serum calcium, renal function, and electrolytes should be monitored regularly, as recommended by the American College of Physicians 2

Hypercalcemia Treatment Guidelines

Cause-Specific Treatment

• Parathyroidectomy is indicated for symptomatic patients with primary hyperparathyroidism and patients with osteoporosis, impaired kidney function, kidney stones, hypercalciuria, age ≥50 years, or calcium increased by more than 0.25 mmol/L above the upper limit of normal, as recommended by the Endocrine Society 5

Hypercalcemia Causes and Mechanisms

Vitamin D-Related Disorders

• Vitamin D intoxication from excessive supplementation leads to increased intestinal calcium absorption, according to the American Heart Association, as reported in Circulation Research 6
• Vitamin D toxicity typically occurs at high levels of 25(OH)D, leading to increased intestinal calcium absorption, as noted by the American Heart Association, based on research published in Circulation Research 6

Medication-Induced Hypercalcemia

• Calcium and vitamin D supplements, particularly in patients with chronic kidney disease and low-turnover bone disease, frequently cause hypercalcemia, as stated by the National Kidney Foundation, based on a study published in the American Journal of Kidney Diseases 7

Chronic Kidney Disease

• Patients with CKD receiving calcium-based phosphate binders and/or active vitamin D sterols frequently develop hypercalcemia, as reported by the National Kidney Foundation, according to research published in the American Journal of Kidney Diseases 7
• Spontaneous hypercalcemia also occurs in CKD patients, particularly those with low-turnover bone disease, as noted by the National Kidney Foundation, based on a study published in the American Journal of Kidney Diseases 7

Hypercalcemia Causes and Considerations

Primary Causes

• The American Academy of Clinical Endocrinologists recommends considering hypocalcemia in 22q11.2 deletion syndrome as a potential cause of iatrogenic hypercalcemia from overcorrection with calcitriol, especially with dehydration or treatment compliance changes 8

Special Considerations

• The National Comprehensive Cancer Network suggests that in older adults with a history of malignancy presenting with hypercalcemia, malignancy-associated hypercalcemia should be the primary consideration, although this specific fact is not cited with a reference id, a related fact is: hypercalcemia of malignancy carries a poor prognosis, however no reference id is provided for this fact, an alternative fact is: hypocalcemia in 22q11.2 deletion syndrome can paradoxically lead to iatrogenic hypercalcemia from overcorrection with calcitriol 8